Literature DB >> 2546585

Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.

L L Shen1, L A Mitscher, P N Sharma, T J O'Donnell, D W Chu, C S Cooper, T Rosen, A G Pernet.   

Abstract

We have proposed a cooperative quinolone-DNA binding model for the inhibition of DNA gyrase. The essential feature of the model is that bound gyrase induces a specific quinolone binding site in the relaxed DNA substrate in the presence of ATP. The binding affinity and specificity are derived from two unique and equally important functional features: the specific conformation of the proposed single-stranded DNA pocket induced by the enzyme and the unique self-association phenomenon (from which the cooperativity is derived) of the drug molecules to fit the binding pocket with a high degree of flexibility. Supporting evidence for and implications of this model are provided.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546585     DOI: 10.1021/bi00435a039

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  73 in total

1.  Effect of emergence of fluoroquinolone resistance on intrinsic expression of P-glycoprotein phenotype in corneal epithelial cells.

Authors:  Megha Barot; Mitan R Gokulgandhi; Megan Haghnegahdar; Pranjali Dalvi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-10       Impact factor: 2.671

2.  Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.

Authors:  F L Alovero; X S Pan; J E Morris; R H Manzo; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Mechanism of action of a novel series of naphthyridine-type ribosome inhibitors: enhancement of tRNA footprinting at the decoding site of 16S rRNA.

Authors:  Linus L Shen; Candace Black-Schaefer; Yingna Cai; Peter J Dandliker; Bruce A Beutel
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 4.  The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.

Authors:  C S Lewin; I Morrissey; J T Smith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

5.  Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.

Authors:  John H Tran; George A Jacoby; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases.

Authors:  Ivan Laponogov; Maninder K Sohi; Dennis A Veselkov; Xiao-Su Pan; Ritica Sawhney; Andrew W Thompson; Katherine E McAuley; L Mark Fisher; Mark R Sanderson
Journal:  Nat Struct Mol Biol       Date:  2009-05-17       Impact factor: 15.369

7.  New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.

Authors:  V Aleixandre; A Urios; G Herrera; M Blanco
Journal:  Mol Gen Genet       Date:  1989-10

8.  Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.

Authors:  V Aleixandre; G Herrera; A Urios; M Blanco
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 9.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

10.  Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.

Authors:  N Nakada; H Shimada; T Hirata; Y Aoki; T Kamiyama; J Watanabe; M Arisawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.